ORAMED PHARMACEUTICALS INC. Contract with Customer, Liability, Noncurrent
ORAMED PHARMACEUTICALS INC. (ORMP) had Contract with Customer, Liability, Noncurrent of $2.00 million as of 2025-12-31, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent › Deferred Revenue, Noncurrent
us-gaap:ContractWithCustomerLiabilityNoncurrent · last filed 2026-08-10
- 2025-12-31: Contract with Customer, Liability, Noncurrent $2.00M.
- 2025-09-30: Contract with Customer, Liability, Noncurrent $2.00M.
- 2025-06-30: Contract with Customer, Liability, Noncurrent $2.00M.
- 2025-03-31: Contract with Customer, Liability, Noncurrent $2.00M.
| Period end | Contract with Customer, Liability, Noncurrent |
|---|---|
| 2025-12-31 | $2.00M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $2.00M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $2.00M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $2.00M 10-Q · filed 2025-05-15 |
| 2024-12-31 | $4.00M 10-K · filed 2026-03-26 |
| 2024-09-30 | $4.00M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $4.00M 10-Q · filed 2024-08-14 |
| 2023-12-31 | $4.00M 10-K · filed 2025-03-27 |
| 2019-05-31 | $10.34M 10-Q · filed 2019-07-10 |
| 2019-02-28 | $11.02M 10-Q · filed 2019-04-10 |
| 2018-11-30 | $10.26M 10-Q · filed 2019-01-14 |
| 2018-08-31 | $11.39M 10-Q · filed 2019-07-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |